Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 62

1.

Stroke in a Child with Hemoglobin SC Disease: A Case Report Describing use of Hydroxyurea after Transfusion Therapy.

Fridlyand D, Wilder C, Clay ELJ, Gilbert B, Pace BS.

Pediatr Rep. 2017 Mar 22;9(1):6984. doi: 10.4081/pr.2017.6984. eCollection 2017 Mar 22.

2.

B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis.

Amara K, Clay E, Yeo L, Ramsköld D, Spengler J, Sippl N, Cameron JA, Israelsson L, Titcombe PJ, Grönwall C, Sahbudin I, Filer A, Raza K, Malmström V, Scheel-Toellner D.

J Autoimmun. 2017 Mar 24. pii: S0896-8411(16)30396-1. doi: 10.1016/j.jaut.2017.03.004. [Epub ahead of print]

3.

Public health impact and economic benefits of quadrivalent influenza vaccine in Latin America.

Jamotte A, Clay E, Macabeo B, Caicedo A, Lopez JG, Bricks L, Romero Prada M, Marrugo R, Alfonso P, Moreno Arévalo B, Franco D, Garcia Diaz L, Isaza de Molto Y.

Hum Vaccin Immunother. 2017 Apr 3;13(4):877-888. doi: 10.1080/21645515.2016.1256928. Epub 2017 Jan 24.

PMID:
28118092
4.

Metabolomics in the Analysis of Inflammatory Diseases.

Kapoor S, Fitzpatrick M, Clay E, Bayley R, Wallace GR, Young SP.

In: Roessner U, editor. Metabolomics [Internet]. Rijeka (HR): InTech; 2012 Feb 10. Chapter 11.

5.

Letter to the Editor: In response to 'Nurse administrators' intentions and considerations in recruiting inactive nurses'.

Clay E.

J Nurs Manag. 2017 Apr;25(3):240. doi: 10.1111/jonm.12439. Epub 2016 Dec 19. No abstract available.

PMID:
27990713
6.

The quality of life of Spanish patients with Huntington's disease measured with H-QoL-I and EQ-5D.

Dorey J, Clay E, Khemiri A, Belhadj A, Cubillo PT, Toumi M.

J Mark Access Health Policy. 2016 Oct 13;4. doi: 10.3402/jmahp.v4.27356. eCollection 2016.

7.

Identification of Preferred DNA-Binding Sites for the Thermus thermophilus Transcriptional Regulator SbtR by the Combinatorial Approach REPSA.

Van Dyke MW, Beyer MD, Clay E, Hiam KJ, McMurry JL, Xie Y.

PLoS One. 2016 Jul 18;11(7):e0159408. doi: 10.1371/journal.pone.0159408. eCollection 2016.

8.

Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe.

Uhart M, Bricout H, Clay E, Largeron N.

Hum Vaccin Immunother. 2016 Sep;12(9):2259-68. doi: 10.1080/21645515.2016.1180490. Epub 2016 May 11.

9.

Ozone-Induced Hypertussive Responses in Rabbits and Guinea Pigs.

Clay E, Patacchini R, Trevisani M, Preti D, Branà MP, Spina D, Page C.

J Pharmacol Exp Ther. 2016 Apr;357(1):73-83. doi: 10.1124/jpet.115.230227. Epub 2016 Feb 2.

10.

Immunogenicity of pneumococcal vaccination in a patient with sickle hemoglobinopathy: a case report.

Clay EL, Burrell T, Belhorn T, Redding-Lallinger R.

Clin Case Rep. 2015 Jul;3(7):618-21. doi: 10.1002/ccr3.276. Epub 2015 Jun 5.

11.

Memantine for treatment of moderate or severe Alzheimer's disease patients in urban China: clinical and economic outcomes from a health economic model.

Hu S, Yu X, Chen S, Clay E, Toumi M, Milea D.

Expert Rev Pharmacoecon Outcomes Res. 2015;15(4):565-78. doi: 10.1586/14737167.2015.1065734.

PMID:
26176750
12.

Budgetary impact of the utilization of buprenorphine/naloxone sublingual film and tablet for Medicaid in the United States.

Asche CV, Clay E, Kharitonova E, Zah V, Ruby J, Aballéa S.

J Med Econ. 2015;18(8):600-11. doi: 10.3111/13696998.2015.1036760. Epub 2015 May 20.

PMID:
25851505
13.

Pharmacotherapeutic strategies for patients treated for depression in UK primary care: a database analysis.

Lamy FX, Chollet J, Clay E, Brignone M, Rive B, Saragoussi D.

Curr Med Res Opin. 2015 Apr;31(4):795-807. doi: 10.1185/03007995.2015.1020362. Epub 2015 Mar 16.

PMID:
25690488
14.

Depression outcomes associated with an intervention implemented in employment training programs for low-income adolescents and young adults.

Tandon SD, Latimore AD, Clay E, Mitchell L, Tucker M, Sonenstein FL.

JAMA Psychiatry. 2015 Jan;72(1):31-9. doi: 10.1001/jamapsychiatry.2014.2022.

PMID:
25391040
15.

Impact of Pharmacoeconomics Guidelines on the International Publications in China.

Rodrigues J, Wu JH, Clay E, Yan J, Toumi M.

Value Health. 2014 Nov;17(7):A799. doi: 10.1016/j.jval.2014.08.485. Epub 2014 Oct 26. No abstract available.

16.

Why it is Difficult for European to Understand the Chinese Market Access Process?

Clay E, Yan J, Chen C, Toumi M.

Value Health. 2014 Nov;17(7):A795. doi: 10.1016/j.jval.2014.08.462. Epub 2014 Oct 26. No abstract available.

17.

Future Impact of Dementia on the Caregiver in China.

Clay E, Yan J, Aballéa S, Toumi M.

Value Health. 2014 Nov;17(7):A769. doi: 10.1016/j.jval.2014.08.305. Epub 2014 Oct 26. No abstract available.

18.

Disease Management, Resource Utilisation and Associated Cost for Moderate and Severe Dementia Patients in China: Results from a Delphi Panel.

Yan J, Ge L, Clay E, Toumi M, Milea D.

Value Health. 2014 Nov;17(7):A768. doi: 10.1016/j.jval.2014.08.301. Epub 2014 Oct 26. No abstract available.

19.

Burden of Illness of Dementia in China.

Yan J, Clay E, Liu C, Yu S, Aballea S, Toumi M.

Value Health. 2014 Nov;17(7):A767. doi: 10.1016/j.jval.2014.08.294. Epub 2014 Oct 26. No abstract available.

20.

Clinical and Economic Outcomes of Memantine Used in Moderate or Severe Dementia Patients in China: Results from a Health Economic Model.

Ge L, Clay E, Yan J, Toumi M, Milea D.

Value Health. 2014 Nov;17(7):A722. doi: 10.1016/j.jval.2014.08.028. Epub 2014 Oct 26. No abstract available.

Supplemental Content

Support Center